Efficacy and safety of helical tomotherapy with daily image guidance in anal canal cancer patients

References

• http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#anal accessed online on 07/07/2015.
   Google Scholar
• Glynne-Jones R, Nilsson PJ, Aschele C, Goh V, Peiffert D, Cervantes A, et al. Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Radiother Oncol 2014;111:330–9.
   PubMed Web of Science ®Google Scholar
• Ferrigno R, Nakamura RA, Dos Santos Novaes PE, Pellizzon AC, Maia MA, Fogarolli RC, et al. Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness. Int J Radiat Oncol Biol Phys 2005;61:1136–42.
   PubMed Web of Science ®Google Scholar
• Huang K, Haas-Kogan D, Weinberg V, Krieg R. Higher radiation dose with a shorter treatment duration improves outcome for locally advanced carcinoma of anal canal. World J Gastroenterol 2007;13:895–900.
   PubMed Web of Science ®Google Scholar
• Gerbaulet A, Pötter R, Mazeron JJ, Meertens H, Van Limbergen E. The GEC ESTRO Handbook of Brachytherapy Bruxelles, 2002 pp. 505–14.
   Google Scholar
• Lestrade L, De Bari B, Pommier P, Montbarbon X, Lavergne E, Ardiet JM, et al. Role of brachytherapy in the treatment of cancers of the anal canal. Long-term follow-up and multivariate analysis of a large monocentric retrospective series. Strahlenther Onkol 2014;190:546–54.
   PubMed Web of Science ®Google Scholar
• Gomez-Millan J, Fernández JR, Medina Carmona JA. Current status of IMRT in head and neck cancer. Rep Pract Oncol Radiother 2013;18:371–5.
   PubMedGoogle Scholar
• Bauman G, Rumble RB, Chen J, Loblaw A, Warde P, Members of the IMRT Indications Expert Panel. Intensity-modulated radiotherapy in the treatment of prostate cancer. Clin Oncol (R Coll Radiol) 2012;24:461–73.
   PubMed Web of Science ®Google Scholar
• De Bari B, Fiorentino A, Arcangeli S, Franco P, D'angelillo RM, Alongi F. From radiobiology to technology: what is changing in radiotherapy for prostate cancer. Expert Rev Anticancer Ther 2014;14:553–64.
   PubMed Web of Science ®Google Scholar
• Ugurluer G, Ballerini G, Moeckli R, Matzinger O, Bourhis J, Ozsahin M. Helical Tomotherapy for the treatment of anal canal cancer: a dosimetric comparison with 3D conformal radiotherapy. Tumori 2015;101:268–72.
   PubMed Web of Science ®Google Scholar
• Cendales R, Vásquez J, Arbelaez J, Bobadilla I, Torres F, Gaitan A. IMRT, RapidArc® and conformal radiotherapy in the treatment of tumours of the anal canal. Ecancermedicalscience 2014;8:469. doi: 10.3332/ecancer.2014.469. eCollection 2014.
   PubMedGoogle Scholar
• Brooks CJ, Lee YK, Aitken K, Hansen VN, Tait DM, Hawkins MA. Organ-sparing Intensity-modulated radiotherapy for anal cancer using the ACTII schedule: a comparison of conventional and intensity-modulated radiotherapy plans. Clin Oncol (R Coll Radiol) 2013;25:155–61.
   PubMed Web of Science ®Google Scholar
• Troussier I, Huguet F, Servagi-Vernat S, Benahim C, Khalifa J, Darmon I, et al. Management of locally advanced anal canal carcinoma with modulated arctherapy and concurrent chemotherapy. Cancer Radiother 2015;19:127–38.
   PubMed Web of Science ®Google Scholar
• Han K, Cummings BJ, Lindsay P, Skliarenko J, Craig T, Le LW, et al. Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer. Int J Radiat Oncol Biol Phys 2014;90:587–94.
   PubMed Web of Science ®Google Scholar
• Kachnic LA, Winter K, Myerson RJ, Goodyear MD, Willins J, Esthappan J, et al. RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 2013;86:27–33.
   PubMed Web of Science ®Google Scholar
• Vieillot S, Fenoglietto P, Lemanski C, Moscardo CL, Gourgou S, Dubois JB, et al. IMRT for locally advanced anal cancer: clinical experience of the Montpellier Cancer Center. Radiat Oncol 2012;7:45
   PubMed Web of Science ®Google Scholar
• National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE), version 4.0. 2009 May. http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf.
   Google Scholar
• Sobin LH, Gospodarowicz MK, Wittekind Ch. Eds. TNM Classification of Malignant Tumors, 7th ed. Wiley-Blackwell, Oxford, 2009.
   Google Scholar
• Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Amer Statist Assn 1958;53:457–81.
   Web of Science ®Google Scholar
• Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50: 163–70.
   PubMedGoogle Scholar
• Ajani JA, Winter KA, Gunderson LL, Pedersen J, Benson AB, III, Thomas CR. Jr, et al. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA 2008;299:1914–21.
   PubMed Web of Science ®Google Scholar
• Salama JK, Mell LK, Schomas DA, Miller RC, Devisetty K, Jani AB, et al. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience. J Clin Oncol 2007;25:4581–6.
   PubMed Web of Science ®Google Scholar
• Kachnic LA, Tsai HK, Coen JJ, Blaszkowsky LS, Hartshorn K, Kwak EL, et al. Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy. Int J Radiat Oncol Biol Phys 2012;82:153–8.
   PubMed Web of Science ®Google Scholar
• Konski A, Garcia M, Jr, John M, Krieg R, Pinover W, Myerson R, et al. Evaluation of planned treatment breaks during radiation therapy for anal cancer: update of RTOG 92-08. Int J Radiat Oncol Biol Phys 2008;72:114–18.
   PubMed Web of Science ®Google Scholar
• Deniaud-Alexandre E, Touboul E, Tiret E, Sezeur A, Houry S, Gallot D, et al. Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal. Int J Radiat Oncol Biol Phys 2003;56:1259–73.
   PubMed Web of Science ®Google Scholar